CAMPTOSAR Side Effects

7023198-8 | Colonic Obstruction, Gastrointestinal Perforation, Haemorrhage, Large Intestine Perforation
on Sep 27, 2010 Male patient from FRANCE , 65 years of age, weighting 176.4 lb, was diagnosed with glioblastoma, brain neoplasm and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: colonic obstruction, gastrointestinal perforation, haemorrhage, large intestine perforation. Camptosar dosage: 260 Mg, Unk. During the same period patient was treated with AVASTIN (850 Mg, Unk) (View Avastin Review and Avastin Label ), TEMOZOLOMIDE (145 Mg, Unk) (View Temozolomide Review and Temozolomide Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7023069-7 | Autoimmune Thrombocytopenia, Contusion, Petechiae, Platelet Count Decreased
Patient was taking Camptosar (View Usage). Patient had the following side effects: autoimmune thrombocytopenia, contusion, petechiae, platelet count decreased on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 130.1 lb, was diagnosed with pancreatic carcinoma metastatic, hypothyroidism and. Camptosar dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), LEUCOVORIN CALCIUM (Unk) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SYNTHROID (100 Mcg Or 175 Mcg) (View Synthroid Review and Synthroid Label ), ZOFRAN (View Zofran Review and Zofran Label ).

7020916-X | Disseminated Intravascular Coagulation, Haemoglobin Decreased, Leukopenia, Neutropenia, Pneumonia, Thrombocytopenia
Adverse event was reported on Sep 17, 2010 by a Female patient taking Camptosar (View Usage) (Dosage: 98.6 Mg/m2, 140 Mg) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: JAPAN , 81 years of age, weighting 116.8 lb, After Camptosar was administered, patient had the following side effects: disseminated intravascular coagulation, haemoglobin decreased, leukopenia, neutropenia, pneumonia (What is pneumonia?), thrombocytopenia. During the same period patient was treated with CALCIUM LEVOFOLINATE (211.3 Mg/m2, 300 Mg) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (352.1 Mg/m2, 500 Mg) (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (200 Mg) (View Bevacizumab Review and Bevacizumab Label ).

7013637-0 | Abdominal Distension, Arthralgia, Constipation, Decreased Appetite, Diarrhoea, Dyspnoea, Fatigue, Haemoglobin Decreased, Injection Site Reaction
on Sep 14, 2010 Female patient from JAPAN , 47 years of age, was diagnosed with gastric cancer and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, arthralgia, constipation (What is constipation?), decreased appetite, diarrhoea, dyspnoea, fatigue, haemoglobin decreased, injection site reaction. Camptosar dosage: 80 Mg/m2, Unk. During the same period patient was treated with TS 1 (Unk, 2x/day) (View Ts-1 Review and Ts-1 Label ).


7013084-1 | Pneumonia
on Sep 13, 2010 Male patient from JAPAN , 67 years of age, weighting 101.4 lb, was diagnosed with colon cancer, benign prostatic hyperplasia, dry skin, stomatitis and was treated with Camptosar (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Camptosar dosage: 200 Mg/m2, Unk. During the same period patient was treated with CALCIUM LEVOFOLINATE (200 Mg/m2, Unk) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (400 Mg/m2, Unk) (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (5 Mg/kg, Unk) (View Avastin Review and Avastin Label ), TAMSULOSIN HCL (0.2 Mg, Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MYSER (Unk) (View Myser Review and Myser Label ), HACHIAZULE (Unk) (View Hachiazule Review and Hachiazule Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6988514-1 | Agitation, Chills, Haemoglobin, Neutrophil Count Abnormal, Pyrexia, Sepsis, Urinary Tract Infection
Patient was taking Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: agitation, chills, haemoglobin, neutrophil count abnormal, pyrexia, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?) on Sep 07, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 185.4 lb, was diagnosed with intestinal adenocarcinoma and. Camptosar dosage: 150 Mg/m2, Every Cycle. During the same period patient was treated with XELODA (800 Mg/m2, 2x/day) (View Xeloda Review and Xeloda Label ), ELOXATIN (100 Mg/m2, Every Cycle) (View Eloxatin Review and Eloxatin Label ), TPN ELECTROLYTES IN PLASTIC CONTAINER (View Tpn Electrolytes In Plastic Container Review and Tpn Electrolytes In Plastic Container Label ), NIACINAMIDE (View Niacinamide Review and Niacinamide Label ), PYRIDOXINE HYDROCHLORIDE (View Pyridoxine Hydrochloride Review and Pyridoxine Hydrochloride Label ). Patient was hospitalized.

6978470-4 | Anaemia, Hyperpyrexia, Leukopenia, Pneumonia, Septic Shock
Adverse event was reported on Sep 03, 2010 by a Female patient taking Camptosar (View Usage) (Dosage: 180 Mg, Cyclic) was diagnosed with metastasis and. Location: ITALY , 70 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, hyperpyrexia, leukopenia, pneumonia (What is pneumonia?), septic shock. During the same period patient was treated with FLUOROURACIL (1000 Mg, Cyclic) (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (180 Mg, Cyclic) (View Calcium Folinate Review and Calcium Folinate Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), DEXAMETHASONE (2 Ml) (View Dexamethasone Review and Dexamethasone Label ), GRANISETRON (1 Unit) (View Granisetron Review and Granisetron Label ), SOLDESAM (1 Unit) (View Soldesam Review and Soldesam Label ), KEPPRA (1500 Mg) (View Keppra Review and Keppra Label ), LENOGRASTIM (1 Unit) (View Lenograstim Review and Lenograstim Label ). Patient was hospitalized.

6976381-1 | Neuropathy Peripheral
on Aug 31, 2010 Female patient from JAPAN , 61 years of age, weighting 119.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Camptosar (View Usage). Patient had the following side effects: neuropathy peripheral. Camptosar dosage: 229.5 Mg, (150 Mg/m2). During the same period patient was treated with CALCIUM LEVOFOLINATE (306 Mg, (200 Mg/m2)) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (612 Mg, (400 Mg/m2)) (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (550 Mg, Unk) (View Avastin Review and Avastin Label ).

6976133-2 | Abdominal Abscess, Pyrexia
on Aug 30, 2010 Male patient from JAPAN , 35 years of age, weighting 116.8 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: abdominal abscess, pyrexia. Camptosar dosage: 240 Mg (155.8 Mg/m2). During the same period patient was treated with CALCIUM LEVOFOLINATE (300 Mg (194.8 Mg/m2)) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (600 Mg (389.6 Mg/m2)) (View Fluorouracil Review and Fluorouracil Label ).

6973335-6 | Autoimmune Thrombocytopenia, Contusion, Petechiae, Platelet Count Decreased
Patient was taking Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune thrombocytopenia, contusion, petechiae, platelet count decreased on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 130.1 lb, was diagnosed with pancreatic carcinoma metastatic, hypothyroidism and. Camptosar dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), LEUCOVORIN CALCIUM (Unk) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SYNTHROID (100 Mcg Or 175 Mcg) (View Synthroid Review and Synthroid Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6970919-6 | Enterocolitis Haemorrhagic, Haemoglobin Decreased, Leukopenia, Neutropenia, Thrombocytopenia
Adverse event was reported on Aug 27, 2010 by a Male patient taking Camptosar (View Usage) (Dosage: 117.6 Mg (80mg/m2), Unk) was diagnosed with non-small cell lung cancer, gastritis, hypertension, constipation (What is constipation?), arrhythmia (What is arrhythmia?), pain (What is pain?) and. Location: JAPAN , 75 years of age, weighting 116.8 lb, Patient had the following side effects: enterocolitis haemorrhagic, haemoglobin decreased, leukopenia, neutropenia, thrombocytopenia. During the same period patient was treated with GEMZAR (1176 Mg (800mg/m2), Unk) (View Gemzar Review and Gemzar Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), TENORMIN (25 Mg, Unk) (View Tenormin Review and Tenormin Label ), MAGNESIUM OXIDE (330 Mg, 3x/day) (View Magnesium Oxide Review and Magnesium Oxide Label ), AZULENE SULFONATE SODIUM/L GLUTAMINE (0.5 G, 3x/day) (View Azulene Sulfonate Sodium/l-glutamine Review and Azulene Sulfonate Sodium/l-glutamine Label ), MEDICON (15 Mg, 3x/day) (View Medicon Review and Medicon Label ), MEXITIL (100 Mg, 3x/day) (View Mexitil Review and Mexitil Label ), LOXONIN (60 Mg, 3x/day) (View Loxonin Review and Loxonin Label ).

6967764-4 | Neuropathy Peripheral
on Aug 26, 2010 Male patient from JAPAN , 62 years of age, weighting 136.7 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: neuropathy peripheral. Camptosar dosage: 244.5 Mg, (150 Mg/m2). During the same period patient was treated with CALCIUM LEVOFOLINATE (326 Mg, (200 Mg/m2)) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (652 Mg, (400 Mg/m2)) (View Fluorouracil Review and Fluorouracil Label ), ERBITUX (652 Mg, (400 Mg/m2)) (View Erbitux Review and Erbitux Label ).

6956616-1 | Pneumatosis Intestinalis
on Aug 18, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with small cell carcinoma and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: pneumatosis intestinalis. Camptosar dosage: Unk. During the same period patient was treated with CARBOPLATIN (Unk) (View Carboplatin Review and Carboplatin Label ).

6944997-4 | Anaemia, Epilepsy, Hyperglycaemia, Hypertension, No Therapeutic Response, Oropharyngeal Candidiasis, Tremor
Patient was taking Camptosar (View Usage). Patient had the following side effects: anaemia, epilepsy (What is epilepsy?), hyperglycaemia, hypertension, no therapeutic response, oropharyngeal candidiasis, tremor on Aug 17, 2010 from SWITZERLAND Additional patient health information: Male patient , 43 years of age, . Camptosar dosage: First Cycle.

6943358-1 | Autoimmune Thrombocytopenia, Contusion, Petechiae, Platelet Count Decreased
Adverse event was reported on Aug 17, 2010 by a Female patient taking Camptosar (View Usage) (Dosage: Unk) was diagnosed with pancreatic carcinoma metastatic, hypothyroidism and. Location: UNITED STATES , 77 years of age, weighting 130.1 lb, After Camptosar was administered, patient had the following side effects: autoimmune thrombocytopenia, contusion, petechiae, platelet count decreased. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), LEUCOVORIN CALCIUM (Unk) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SYNTHROID (100 Mcg Or 175 Mcg) (View Synthroid Review and Synthroid Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6943229-0 | Chest Discomfort, Dyspnoea, Muscle Spasms
on Aug 19, 2010 Female patient from MEXICO , 56 years of age, weighting 110.2 lb, was diagnosed with neoplasm malignant and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, dyspnoea, muscle spasms. Camptosar dosage: 100 Mg, Unk.

6933881-8 | Paraesthesia, Skin Warm
on Aug 11, 2010 Female patient from FRANCE , 44 years of age, was diagnosed with metastases to liver and was treated with Camptosar (View Usage). Patient had the following side effects: paraesthesia, skin warm. Camptosar dosage: Unk. During the same period patient was treated with ONDANSETRON (View Ondansetron Review and Ondansetron Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ATROPINE (View Atropine Review and Atropine Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6932423-0 | Autoimmune Thrombocytopenia, Contusion
Patient was taking Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: autoimmune thrombocytopenia, contusion on Aug 11, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 130.0 lb, was diagnosed with pancreatic carcinoma metastatic, hypothyroidism and. Camptosar dosage: Unk. During the same period patient was treated with FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ), GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), LEUCOVORIN CALCIUM (Unk) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), SYNTHROID (100 Mcg Or 175 Mcg) (View Synthroid Review and Synthroid Label ).

6925419-6 | Dehydration, Dysuria, Pyrexia
Adverse event was reported on Aug 06, 2010 by a Female patient taking Camptosar (View Usage) (Dosage: 275 Mg, Cyclic) was diagnosed with metastases to liver and. Location: ITALY , 67 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, dysuria, pyrexia. During the same period patient was treated with CALCIUM FOLINATE (150 Mg, Cyclic) (View Calcium Folinate Review and Calcium Folinate Label ), FLUOROURACIL (620 Mg, Cyclic) (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (290 Mg, Cyclic) (View Bevacizumab Review and Bevacizumab Label ).

6923106-1 | Anaemia, Hyperpyrexia, Leukopenia, Pneumonia
on Aug 05, 2010 Female patient from ITALY , 70 years of age, was diagnosed with metastasis and was treated with Camptosar (View Usage). Patient had the following side effects: anaemia, hyperpyrexia, leukopenia, pneumonia (What is pneumonia?). Camptosar dosage: 180 Mg, Cyclic. During the same period patient was treated with FLUOROURACIL (1000 Mg, Cyclic) (View Fluorouracil Review and Fluorouracil Label ), CALCIUM FOLINATE (180 Mg, Cyclic) (View Calcium Folinate Review and Calcium Folinate Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), DEXAMETHASONE (2 Ml) (View Dexamethasone Review and Dexamethasone Label ), GRANISETRON (1 Unit) (View Granisetron Review and Granisetron Label ), SOLDESAM (1 Unit) (View Soldesam Review and Soldesam Label ), KEPPRA (1500 Mg) (View Keppra Review and Keppra Label ), LENOGRASTIM (1 Unit) (View Lenograstim Review and Lenograstim Label ). Patient was hospitalized.

6921739-X | Back Pain, Blood Amylase Increased, Lipase Increased
on Mar 23, 2010 Male patient from UNITED STATES , 59 years of age, weighting 138.0 lb, was diagnosed with oesophageal carcinoma and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: back pain (What is back pain?), blood amylase increased, lipase increased. Camptosar dosage: Injection. During the same period patient was treated with ERBITUX (View Erbitux Review and Erbitux Label ).

6921711-X | Diarrhoea, Pulmonary Embolism
Patient was taking Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, pulmonary embolism (What is pulmonary embolism?) on Jul 28, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with colorectal cancer metastatic and. Camptosar dosage: 232 Mg, Everyseven Day;, Intravenous. During the same period patient was treated with MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), OMEPRAXOLE (OMEPRAZOLE) (View Omepraxole (omeprazole) Review and Omepraxole (omeprazole) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), COLACE (DOCUSATE SODIUM) (View Colace (docusate Sodium) Review and Colace (docusate Sodium) Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ). Patient was hospitalized.

6910900-6 | Agitation, Chills, Haemoglobin, Neutrophil Count Abnormal, Pyrexia, Sepsis, Urinary Tract Infection
Adverse event was reported on Jul 29, 2010 by a Male patient taking Camptosar (View Usage) (Dosage: 150 Mg/m2, Every 3 Weeks) was diagnosed with intestinal adenocarcinoma and. Location: UNITED STATES , 65 years of age, weighting 185.4 lb, Patient had the following side effects: agitation, chills, haemoglobin, neutrophil count abnormal, pyrexia, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). During the same period patient was treated with XELODA (1600 Mg/m2, Cyclic) (View Xeloda Review and Xeloda Label ), ELOXATIN (100 Mg/m2, Every 3 Weeks) (View Eloxatin Review and Eloxatin Label ), TPN ELECTROLYTES IN PLASTIC CONTAINER (View Tpn Electrolytes In Plastic Container Review and Tpn Electrolytes In Plastic Container Label ). Patient was hospitalized.

6896361-4 | Decreased Appetite, Lower Respiratory Tract Infection, Sinusitis
on Jan 05, 2009 Female patient from UNITED STATES , weighting 96.98 lb, was diagnosed with bile duct cancer and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: decreased appetite, lower respiratory tract infection, sinusitis (What is sinusitis?). Camptosar dosage: Unk. During the same period patient was treated with GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), XANAX (Unk) (View Xanax Review and Xanax Label ), LORTAB (Unk) (View Lortab Review and Lortab Label ), OXYCODONE (Unk) (View Oxycodone Review and Oxycodone Label ).

6893703-0 | Arthralgia, Burning Sensation, Erythema, Fatigue, Joint Swelling
on Jan 13, 2010 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with ovarian cancer and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, burning sensation, erythema, fatigue, joint swelling. Camptosar dosage: 40 Mg, Cyclic. During the same period patient was treated with CARBOPLATIN (100 Mg, Cyclic) (View Carboplatin Review and Carboplatin Label ), PAXIL (Unk) (View Paxil Review and Paxil Label ).

6893053-2 | Pulmonary Embolism
Patient was taking Camptosar (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Feb 18, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 216.9 lb, was diagnosed with colon cancer metastatic and. Camptosar dosage: On Days 1 And 8, Every 3 Weeks. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), CETUXIMAB (View Cetuximab Review and Cetuximab Label ).

6893007-6 | Breast Cancer Metastatic, Disease Progression
Adverse event was reported on Dec 30, 2008 by a Female patient taking Camptosar (View Usage) (Dosage: 150 Mg, Weekly Then Later 2 Weeks On, One Week Off) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , weighting 106.0 lb, After Camptosar was administered, patient had the following side effects: breast cancer metastatic, disease progression. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), MEGACE (View Megace Review and Megace Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SALT TABLETS (View Salt Tablets Review and Salt Tablets Label ), PROTONIX (View Protonix Review and Protonix Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6892981-1 | Blister, Erythema, Pruritus, Rash
on Dec 10, 2008 Male patient from UNITED STATES , weighting 183.0 lb, was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: blister, erythema, pruritus, rash (What is rash?). Camptosar dosage: 1 Every 2 Weeks. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), KYTRIL (View Kytril Review and Kytril Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BENADRYL (View Benadryl Review and Benadryl Label ), ATROPINE (View Atropine Review and Atropine Label ), TAGAMET (View Tagamet Review and Tagamet Label ), CLARITIN (View Claritin Review and Claritin Label ).

6892939-2 | Dyspnoea, Flushing, Hypersensitivity
on Nov 18, 2008 Male patient from UNITED STATES , weighting 222.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Camptosar (View Usage). Patient had the following side effects: dyspnoea, flushing, hypersensitivity. Camptosar dosage: .

6892702-2 | Anaemia, Erythema, Rash
Patient was taking Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: anaemia, erythema, rash (What is rash?) on Aug 19, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 176.6 lb, was diagnosed with non-small cell lung cancer, prophylaxis and. Camptosar dosage: . During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), AVASTIN (View Avastin Review and Avastin Label ).

6892185-2 | Anaemia, Colitis, Dehydration, Diarrhoea, Fluid Retention, Hepatic Function Abnormal, Hypokalaemia, Hypomagnesaemia, Hypovolaemia
Adverse event was reported on Feb 27, 2008 by a Male patient taking Camptosar (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: UNITED STATES , weighting 184.1 lb, Patient experienced the following unwanted or unexpected effects: anaemia, colitis, dehydration, diarrhoea, fluid retention, hepatic function abnormal, hypokalaemia, hypomagnesaemia, hypovolaemia. During the same period patient was treated with ATROPINE (View Atropine Review and Atropine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), XELODA (View Xeloda Review and Xeloda Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6892167-0 | Abdominal Pain, Anaemia, Cough, Disease Progression, Flatulence, Leukopenia, Oesophageal Carcinoma, Thrombocytopenia
on Feb 13, 2008 Male patient from UNITED STATES , weighting 141.1 lb, was diagnosed with oesophageal carcinoma, pain (What is pain?), nausea (What is nausea?) and was treated with Camptosar (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, cough, disease progression, flatulence, leukopenia, oesophageal carcinoma, thrombocytopenia. Camptosar dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ROXICET (5/325 5cc,every Four Hours As Needed) (View Roxicet Review and Roxicet Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), COMPAZINE (Every Four Hours As Needed) (View Compazine Review and Compazine Label ), ZOFRAN (As Needed) (View Zofran Review and Zofran Label ), REMERON (At Bedtime) (View Remeron Review and Remeron Label ).

6892116-5 | Colorectal Cancer, Disease Progression, Muscle Spasms, Nausea
on Feb 04, 2008 Male patient from UNITED STATES , weighting 249.1 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: colorectal cancer (What is colorectal cancer?), disease progression, muscle spasms, nausea (What is nausea?). Camptosar dosage: On Day 1 Every 3 Weeks. During the same period patient was treated with FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CETUXIMAB (On Days 1, 8 And 15) (View Cetuximab Review and Cetuximab Label ).

6892109-8 | Muscle Spasms, Nausea
Patient was taking Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms, nausea (What is nausea?) on Jan 29, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 185.0 lb, was diagnosed with colon cancer and. Camptosar dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6891996-7 | Abdominal Pain, Dizziness, Hyperhidrosis, Nausea
Adverse event was reported on Nov 29, 2007 by a Male patient taking Camptosar (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: UNITED STATES , weighting 178.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?). During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ).

6891945-1 | Abdominal Discomfort, Diarrhoea, Hyperhidrosis, Muscle Spasms, Nausea
on Jan 07, 2008 Female patient from UNITED STATES , weighting 201.9 lb, was diagnosed with colon cancer and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: abdominal discomfort, diarrhoea, hyperhidrosis, muscle spasms, nausea (What is nausea?). Camptosar dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6891936-0 | Cerebrovascular Accident, Confusional State, Hemiparesis, Speech Disorder
on Jan 07, 2008 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with colon cancer metastatic and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, confusional state, hemiparesis, speech disorder. Camptosar dosage: 1 Every 2 Weeks. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), XELODA (View Xeloda Review and Xeloda Label ).

6891925-6 | Abdominal Pain, Nausea
Patient was taking Camptosar (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?) on Nov 29, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 169.8 lb, was diagnosed with colon cancer and. Camptosar dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6891921-9 | Abdominal Pain
Adverse event was reported on Dec 05, 2007 by a Female patient taking Camptosar (View Usage) (Dosage: ) was diagnosed with colorectal cancer (What is colorectal cancer?) and. Location: UNITED STATES , 70 years of age, weighting 129.0 lb, After Camptosar was administered, patient had the following side effects: abdominal pain (What is abdominal pain?).

6891908-6 | Disease Progression, Neoplasm Malignant
on Nov 14, 2007 Female patient from UNITED STATES , 36 years of age, was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, neoplasm malignant. Camptosar dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ).

6891902-5 | Pyrexia
on Jan 14, 2008 Female patient from UNITED STATES , weighting 182.0 lb, was diagnosed with colon cancer metastatic and was treated with Camptosar (View Usage). Patient had the following side effects: pyrexia. Camptosar dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ), ARANESP (View Aranesp Review and Aranesp Label ), KYTRIL (View Kytril Review and Kytril Label ), BENADRYL (View Benadryl Review and Benadryl Label ), PREMPRO (View Prempro Review and Prempro Label ), CELEXA (View Celexa Review and Celexa Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), AMBIEN (View Ambien Review and Ambien Label ).

6891878-0 | Anxiety, Hyperhidrosis
Patient was taking Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: anxiety (What is anxiety?), hyperhidrosis on Nov 17, 2007 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 163.0 lb, was diagnosed with colon cancer and. Camptosar dosage: .

6891858-5 | Diarrhoea
Adverse event was reported on Nov 14, 2007 by a Male patient taking Camptosar (View Usage) (Dosage: ) was diagnosed with oesophageal cancer metastatic and. Location: UNITED STATES , 67 years of age, weighting 94.01 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6891827-5 | Abdominal Pain, Diarrhoea, Flatulence, Weight Decreased
on Mar 11, 2008 Male patient from UNITED STATES , weighting 163.3 lb, was diagnosed with pancreatic carcinoma and was treated with Camptosar (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, flatulence, weight decreased. Camptosar dosage: . During the same period patient was treated with LOMOTIL (View Lomotil Review and Lomotil Label ), LOPERAMIDE HYDROCHLORIDE (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ).

6891723-3 | Blood Magnesium Decreased, Colorectal Cancer Metastatic, Diarrhoea, Disease Progression
on Oct 12, 2007 Female patient from UNITED STATES , weighting 116.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: blood magnesium decreased, colorectal cancer metastatic, diarrhoea, disease progression. Camptosar dosage: . During the same period patient was treated with CETUXIMAB (View Cetuximab Review and Cetuximab Label ). Patient was hospitalized.

6891702-6 | Blood Potassium Decreased, Diarrhoea
Patient was taking Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, diarrhoea on Feb 06, 2008 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 160.9 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Camptosar dosage: . Patient was hospitalized.

6891589-1 | Nausea
Adverse event was reported on Aug 29, 2007 by a Male patient taking Camptosar (View Usage) (Dosage: Weekly) was diagnosed with rectal cancer, metastases to liver and. Location: UNITED STATES , 53 years of age, weighting 255.0 lb, Patient had the following side effects: nausea (What is nausea?). During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ).

6891550-7 | Diarrhoea
on Aug 07, 2007 Male patient from UNITED STATES , weighting 242.5 lb, was diagnosed with abdominal neoplasm and was treated with Camptosar (View Usage). After Camptosar was administered, patient had the following side effects: diarrhoea. Camptosar dosage: Every Day. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), MORPHINE (View Morphine Review and Morphine Label ), KYTRIL (View Kytril Review and Kytril Label ), EMEND (View Emend Review and Emend Label ).

6891538-6 | Muscle Spasms
on Oct 18, 2007 Female patient from UNITED STATES , weighting 163.0 lb, was diagnosed with gastrointestinal disorder and was treated with Camptosar (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms. Camptosar dosage: . During the same period patient was treated with FLUOROURACIL/FOLINIC ACID/IRINOTECAN (View Fluorouracil/folinic Acid/irinotecan Review and Fluorouracil/folinic Acid/irinotecan Label ).

6891521-0 | Incorrect Dose Administered, Medical Device Complication, No Adverse Event
Patient was taking Camptosar (View Usage). Patient had the following side effects: incorrect dose administered, medical device complication, no adverse event on Sep 22, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 213.0 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Camptosar dosage: . During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), PROTONIX (View Protonix Review and Protonix Label ), COMPAZINE (View Compazine Review and Compazine Label ), LORTAB (View Lortab Review and Lortab Label ).